KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Jazz Pharmaceuticals (JAZZ) Income from Continuing Operations (2016 - 2025)

Jazz Pharmaceuticals has reported Income from Continuing Operations over the past 16 years, most recently at 203465000.0 for Q4 2025.

  • Quarterly results put Income from Continuing Operations at 203465000.0 for Q4 2025, up 6.47% from a year ago — trailing twelve months through Dec 2025 was 72358000.0 (down 112.88% YoY), and the annual figure for FY2025 was 355459000.0, down 163.28%.
  • Income from Continuing Operations for Q4 2025 was 203465000.0 at Jazz Pharmaceuticals, down from 251459000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for JAZZ hit a ceiling of 251459000.0 in Q3 2025 and a floor of 718384000.0 in Q2 2025.
  • Median Income from Continuing Operations over the past 5 years was 70401000.0 (2023), compared with a mean of 9101631.58.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 641.93% in 2022 and later soared 1108.6% in 2023.
  • Jazz Pharmaceuticals' Income from Continuing Operations stood at 32347000.0 in 2021, then tumbled by 641.93% to 239993000.0 in 2022, then soared by 139.42% to 94603000.0 in 2023, then surged by 102.0% to 191102000.0 in 2024, then increased by 6.47% to 203465000.0 in 2025.
  • The last three reported values for Income from Continuing Operations were 203465000.0 (Q4 2025), 251459000.0 (Q3 2025), and 718384000.0 (Q2 2025) per Business Quant data.